GLP-1 & Metabolic
Cagrisema
Cagrilintide + semaglutide blend
A research blend of cagrilintide (a long-acting amylin analog) with semaglutide (a GLP-1 receptor agonist). The pairing is studied for the combined effect of amylin and incretin signaling on metabolic endpoints.
Purity
—
Form
—
Available strengths
5 mg / 5 mg
CAS number
—
Select strength
Request wholesale pricing Related products
View all →
More in GLP-1 & Metabolic
Other compounds AP Labs supplies in this category.